Literature DB >> 15550154

Toxic epidermal necrolysis treated with low-dose intravenous immunoglobulin: immunohistochemical study of Fas and Fas-ligand expression.

K Ito, H Hara, T Okada, H Shimojima, H Suzuki.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15550154     DOI: 10.1111/j.1365-2230.2004.01635.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  6 in total

1.  Toxic Epidermal Necrolysis Managed with Immunoglobulin.

Authors:  G D Choudhury; V Agarwal
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

3.  Cephazolin-induced toxic epidermal necrolysis treated with intravenous immunoglobulin and N-acetylcysteine.

Authors:  Carlos Saavedra; Paola Cárdenas; Héctor Castellanos; Kateir Contreras; J R Castro
Journal:  Case Reports Immunol       Date:  2012-04-19

Review 4.  Toxic epidermal necrolysis.

Authors:  Wolfram Hoetzenecker; Tarun Mehra; Ieva Saulite; Martin Glatz; Peter Schmid-Grendelmeier; Emmanuella Guenova; Antonio Cozzio; Lars E French
Journal:  F1000Res       Date:  2016-05-20

5.  Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's disease.

Authors:  Isabelle St-Amour; Mélanie Bousquet; Isabelle Paré; Janelle Drouin-Ouellet; Francesca Cicchetti; Renée Bazin; Frédéric Calon
Journal:  J Neuroinflammation       Date:  2012-10-09       Impact factor: 8.322

Review 6.  Adverse cutaneous drug eruptions: current understanding.

Authors:  W Hoetzenecker; M Nägeli; E T Mehra; A N Jensen; I Saulite; P Schmid-Grendelmeier; E Guenova; A Cozzio; L E French
Journal:  Semin Immunopathol       Date:  2015-11-09       Impact factor: 11.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.